Drug Type Small molecule drug |
Synonyms LPA1R inhibitors (Bristol Myers Squibb/Inception Sciences/PharmAkea), BMT-053011 |
Target |
Action antagonists |
Mechanism LPAR1 antagonists(Lysophosphatidic acid receptor Edg-2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Discovery | United States | - | |
Nonalcoholic Steatohepatitis | Discovery | United States | - | |
Nonalcoholic Steatohepatitis | Discovery | United States | - |